Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCareAcross
About this trial
The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.
Eligibility criteria
Qualifiers
Age of ≥ 18 years.
Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
Ability to understand and operate in a digital environment.
Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
Disqualifiers
Limited ability or willingness to report side-effects on an online platform.
Performance status >3.
Life expectancy of <6 months.
Participation in an interventional clinical trial with investigational drugs or devices.
Trial design
Treatments tested in this trial
- Digital support
Treatment groups
108 Participants
are divided into 2 treatment groupsSponsors and collaborators
CareAcross
Lead sponsor
Hellenic Group of Sarcomas & Rare Cancers (HGSRC)
Collaborator
Source ClinicalTrials.gov